Soleil Boughton - 06 Jan 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Legal Officer
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
06 Jan 2025
Net transactions value
-$6,484,061
Form type
4
Filing time
07 Jan 2025, 16:48:48 UTC
Previous filing
17 Dec 2024
Next filing
23 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $276,456 +113,768 +62% $2.43 298,480 06 Jan 2025 Direct F1
transaction HIMS Class A Common Stock Options Exercise $702,678 +140,255 +47% $5.01 438,735 06 Jan 2025 Direct F1
transaction HIMS Class A Common Stock Sale $6,623,195 -238,932 -54% $27.72 199,803 06 Jan 2025 Direct F1
transaction HIMS Class A Common Stock Sale $840,000 -30,000 -15% $28.00 169,803 06 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -113,768 -100% $0.000000 0 06 Jan 2025 Class A Common Stock 113,768 $2.43 Direct F1, F2
transaction HIMS Stock Option (right to buy) Options Exercise $0 -140,255 -17% $0.000000 694,154 06 Jan 2025 Class A Common Stock 140,255 $5.01 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
F2 The option award vests over a four year period, with 1/48 of the shares subject to the stock option vesting when the Reporting Person completes each month of continuous Service beginning February 12, 2020.
F3 The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.